Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum. Smeaton LM, Kileel EM, Grinsztejn B, Gardner EM, et al. J Infect Dis 2020;222.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Smeaton LM, Kileel EM, Grinsztejn B, Gardner EM, et al. Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender Spectrum. J Infect Dis 2020;222.
PMID: 32645160